Dialyzer Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 4.26 Billion |
| Market Size (2030) | USD 5.51 Billion |
| CAGR (2025 - 2030) | 5.29% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Dialyzer Market Analysis
The Dialyzer Market size is estimated at USD 4.26 billion in 2025, and is expected to reach USD 5.51 billion by 2030, at a CAGR of 5.29% during the forecast period (2025-2030).
Factors propelling the market's growth include the increasing burden of renal disorders and associated risk diseases, advancements in technology, and easy access to reimbursement policies, and strategic activities by manufacturers and others.
The increasing burden of renal disorders is expected to drive the growth of the dialyzer market, primarily because of the rising demand for effective renal replacement therapies. The prevalence of Chronic kidney disease (CKD) and end-stage renal disease (ESRD) is increasing globally due to factors like diabetes, hypertension, and an aging population. As the number of patients with these conditions rises, so does the demand for dialysis treatments.
As more people develop chronic kidney disease due to factors like aging populations and increasing rates of diabetes as well as hypertension, there is a growing demand for dialysis treatment. Chronic kidney disease (CKD) can eventually lead to end-stage renal disease (ESRD), where kidneys can no longer function effectively. For instance, according to Kidney Care UK, in May 2024, it is estimated that approximately 7.2 million individuals in the United Kingdom will be living with chronic kidney disease (CKD) across stages 1-5 in 2024. Out of these, around 3.25 million are in the advanced stages (3-5), where symptom management becomes increasingly challenging. Thus, dialyzers are essential in hemodialysis, a critical therapy for managing CKD by filtering waste products and excess fluids from the blood, which will fuel market expansion in the forecast period.
In addition, due to a shortage of donor kidneys relative to demand, patients often face prolonged waiting periods for transplantation. During this time, dialysis becomes essential for managing kidney failure and maintaining patients' health. For instance, according to the Kidney Care UK, in May 2024, nearly 4,600 transplants were conducted in the United Kingdom in 2022/23, while approximately 7,000 individuals are currently on the transplant waiting list in 2024. The transplant list grows by over ten individuals daily. This increases the demand for dialyzers, which are essential for dialysis treatments. Therefore, the growing transplant list, drives the market as it highlights the rising need for effective dialysis solutions for patients awaiting transplants, thereby boosting demand for dialyzers.
According to the same source, on average, patients in the United Kingdom wait approximately two and a half years for a transplant, although this duration varies significantly across regions. Only 20% of individuals with kidney failure receive a transplant. Hence, prolonged wait times increase the number of patients requiring dialysis as a bridge therapy until a suitable donor kidney becomes available. This extended demand for dialysis treatments is further anticipated to fuel the growth of the market in the studied period.
Furthermore, advancements in renal care technologies are rapidly evolving to address the complexities and challenges of treating kidney disease. Key innovations include silicon nanopore membranes, tissue engineering for renal cell bioreactors, and dialysate regeneration systems. For instance, as per the article published by Membranes Journal in February 2022, ongoing advancements in silicon nanopore membranes, tissue engineering for renal cell bioreactors, and dialysate regeneration aim to address the limitations of current artificial kidney technologies. These innovations are expected to facilitate the development of wearable or implantable artificial kidneys.
Additionally, in April 2023, Medtronic and DaVita launched of Mozarc Medical, a joint venture aimed at developing advanced kidney care technologies with a focus on at-home treatments. The new company is set to transform kidney care by introducing innovative health technologies designed to improve patient outcomes. This strategic partnership is expected to enhance market reach and potentially increase the customer base for both companies. Therefore, such marketing activities by players such as launches will drive the growth of market over the forecast period.
Additionally, manufacturers focus on launches as well as acquisitions to increase the expansion in the global market. For instance, in January 2023, Baxter International Inc. launched of its new EverlinQ endoAVF System. The EverlinQ endoAVF System is a catheter-based dialyzer that is designed to create a connection between a patient's vein and artery. This connection allows blood to be filtered more efficiently than with traditional dial. Therefore such initiaves by manufcatures such as launches wil drive the grwoth of market over the forecast period.
Hence, the above-mentioned factors such as growing chronic kidney disease, rising waiting time for kidney transplantation, advancements in renal care technologies, and streathrtic activities conducted by manufactures such as launches will help to drive the growth of the market over the forecast period. However, high treatment cost and complications associated with dialysis procedure such as severe anemia and fluid overload, may hamper the growth of the market.
Dialyzer Market Trends
Reusable Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
A reusable dialyzer is a medical device that filters and purifies the blood of patients suffering from renal failure. It is designed to be used multiple times and can be sterilized between uses. This type of dialyzer features a semi-permeable membrane that separates blood from dialysis fluid to remove waste products and excess fluids. Reusable dialyzers offer cost and environmental benefits by reducing the need for constant replacement.
Reusable dialyzers are expected to drive the dialyzer market due to their cost-effectiveness and reduced environmental impact. These dialyzers can be cleaned and sterilized for multiple uses, lowering overall treatment costs and generating less medical waste than single-use dialyzers. For instance, as per the article published in the Journal of the Nephrology Society of Thailand (JNST) in December 2023, healthcare professionals have reprocessed dialyzers for over five decades. In countries with limited resources, reusing dialyzers can lead to up to 30% cost savings, thereby increasing access to hemodialysis for more patients.
Additionally, as per the article published in Wolter Kluwer in January 2024, dialyzer reuse has proven safe and cost-effective, especially for high-flux dialyzers and those focused on high urea removal. This practice of reusing dialyzers continues in various regions globally, notably in countries with constrained resources for kidney replacement therapies. Hence, the rising use of reprocessed dialyzers in the healthcare industry enhances market growth by offering a more affordable and eco-friendly alternative to single-use options, aligning with cost-saving and sustainability goals in dialysis care.
Moreover, the prevalance of chronic kidney disease is growing day by day. For instance, a sper the article published by Kidney Research UK in June 2023, 3.9 Million cases occurs in the year 2023. Therefore, the growing cases of chronic kidney disease will drive the growth of market over the forecast period.
Reusing dialyzers can help minimize the drop in platelet counts associated with hemodialysis by reducing the frequency of patient exposure to new, potentially inflammatory dialyzer materials. Reprocessed dialyzers often maintain consistent performance and biocompatibility over multiple uses, which helps in mitigating adverse reactions and platelet consumption.
For instance, as per the article published by the Brazilian Journal of Nephrology in January 2022, the reuse of the dialyzer is a safe and effective practice employed worldwide. In recent developments, attention has turned to the reuse of dialyzers. Reusing dialyzers has been shown to reduce the drop in platelet counts commonly associated with hemodialysis. Therefore, the ability of reusable dialyzers to reduce platelet count drops during hemodialysis boosts their attractiveness to healthcare providers, thereby driving market growth by improving patient safety and treatment efficacy.
Hence, the factors mentioned earlier, such as the adoption of reusable dialyzers due to their cost-effectiveness and reduced environmental impact and their ability to reduce platelet count drops, are expected to continue the growth of the reusable segment in the coming years.
North America is Expected to Hold a Significant Market Share Over the Forecast Period
Some factors driving the market growth in the North American region include the growing cases of kidney failures, the increasing burden of renal disorders, the rising demand for home dialysis therapies, and the presence of major key players in the region.
As more kidney diseases are diagnosed, a larger patient pool progresses towards needing dialysis, especially hemodialysis, due to its prevalence. This translates to demand for hemodialyzers. For instance, according to the American Kidney Fund, in January 2024, approximately 35.5 million Americans are affected by kidney disease, with 808 thousand experiencing kidney failure. Out of these, over 557 thousand depend on dialysis. This trend is particularly concerning as kidney disease now impacts over 14% of American adults, with individuals from minority groups at a higher risk of kidney failure.
Moreover, according to the Kidney Foundation of Canada, in February 2023, kidney disease affects 1 in 10 Canadians, translating to approximately 4 million individuals in 2022. Diabetes accounts for 38% of kidney failure cases. Notably, 45% of newly diagnosed patients are below 65. Currently, over 53,000 Canadians are undergoing treatment for kidney failure in 2023. Hence, more kidney disease and diagnosed cases translate to more patients eventually needing hemodialysis, and increasing demand for dialyzers will drive the market growth in the North American region.
Hence, more kidney disease and diagnosed cases translate to more patients eventually needing dialysis, and increasing demand for dialyzers in the short term will drive market growth in the North American region. As more patients and healthcare providers adopt home dialysis due to its benefits, such as improved quality of life and reduced healthcare facility visits, the demand for appropriate dialyzers grows, fueling market expansion in the North American region.
Moreover, the rising company activities in developing advanced hemodialysis machines and consumables also contribute to the market growth. For instance, in March 2022, Nipro Medical Corporation launched the SURDIAL DX Hemodialysis System in the United States. The system is designed to create an optimal dialysis treatment experience for patients and clinicians.
Therefore, owing to the factors above, including the growing cases of kidney disease, growing demand of home dialysis therpies, and the presence of major key players, the studied market is expected to grow significantly in the region over the forecast period.
Dialyzer Industry Overview
The dialyzer market is semi-consolidated due to the presence of several companies operating globally and regionally. Strategic initiatives taken by these companies, such as product launches, mergers, and acquisitions, are expected to positively impact the market. Some of the players in the dialyzer market are Allmed Medical Care Holdings Limited, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter, Fresenius Medical Care AG, and others.
Dialyzer Market Leaders
-
Asahi Kasei Corporation
-
B. Braun Melsungen AG
-
Fresenius Medical Care AG
-
Baxter
-
Allmed Medical Care Holdings Limited
- *Disclaimer: Major Players sorted in no particular order
Dialyzer Market News
- February 2024: Fresenius Medical Care (FME) received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 5008X Hemodialysis System. This approval enables the company to introduce a new standard of care in dialysis therapy for individuals with kidney diseases in the United States.
- April 2024: Royal Victoria Regional Health Centre (RVH) introduced a Home Hemodialysis Program, offering patients with chronic kidney disease enhanced treatment flexibility. Home hemodialysis, compared to in-center sessions, not only grants patients greater autonomy but also promises improved health outcomes and a higher quality of life.
Dialyzer Industry Segmentation
Dialyzers are medical devices, also known as artificial kidneys, used to substitute the function of the kidney during acute or chronic kidney failure. They are primarily used for hemodialysis procedures. Dialyzers are artificial filters that purify the blood by extracting excess water and metabolic wastes from the blood. These devices incorporate a diverse array of membranes, commonly referred to as hollow fibers, which utilize the principle of diffusion to purify the blood.
The dialyzer market is segmented by type, usage type, end-user, and geography. By type, the market is segmented into high-flux dialyzers and low-flux dialyzers. By usage type, the market is segmented into disposable and reusable. By end user, the market is segmented into hospitals and Clinics, ambulatory surgical centers, home care settings, and dialysis centers. By Geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Type | High-Flux Dialyzer | ||
| Low-Flux Dialyzer | |||
| By Usage Type | Disposable | ||
| Reusable | |||
| By End User | Hospitals and Clinics | ||
| Ambulatory Surgical Centers | |||
| Home Care Settings | |||
| Dialysis Centers | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle-East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| High-Flux Dialyzer |
| Low-Flux Dialyzer |
| Disposable |
| Reusable |
| Hospitals and Clinics |
| Ambulatory Surgical Centers |
| Home Care Settings |
| Dialysis Centers |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle-East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Dialyzer Market Research FAQs
How big is the Dialyzer Market?
The Dialyzer Market size is expected to reach USD 4.26 billion in 2025 and grow at a CAGR of 5.29% to reach USD 5.51 billion by 2030.
What is the current Dialyzer Market size?
In 2025, the Dialyzer Market size is expected to reach USD 4.26 billion.
Who are the key players in Dialyzer Market?
Asahi Kasei Corporation, B. Braun Melsungen AG, Fresenius Medical Care AG, Baxter and Allmed Medical Care Holdings Limited are the major companies operating in the Dialyzer Market.
Which is the fastest growing region in Dialyzer Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Dialyzer Market?
In 2025, the North America accounts for the largest market share in Dialyzer Market.
What years does this Dialyzer Market cover, and what was the market size in 2024?
In 2024, the Dialyzer Market size was estimated at USD 4.03 billion. The report covers the Dialyzer Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Dialyzer Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
